Sedona Sweeney

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 17

Top Topics

Acinetobacter Baumannii

Top Venues

medRxiv : the preprint server for health sciences

Wellcome open research

BMJ global health

This page only lists publications with an associated author ORCID identifier.

Publications

Melike Hazal Can, Sedona Sweeney, Brian W Allwood, Susan E Dorman, Ted Cohen, Nicolas A Menzies
Implications of progressive lung damage and post-TB sequelae for the health benefits of prompt TB diagnosis in high HIV prevalence settings: a mathematical modeling analysis. medRxiv : the preprint server for health sciences (2024)
Lyndon P James, Fayette Klaassen, Sedona Sweeney, Jennifer Furin, Molly F Franke, Reza Yaesoubi, Dumitru Chesov, Nelly Ciobanu, Alexandru Codreanu, Valeriu Crudu, Ted Cohen, Nicolas A Menzies
Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis. PLoS medicine 21 (5) (2024)
Lyndon P James, Fayette Klaassen, Sedona Sweeney, Jennifer Furin, Molly F Franke, Reza Yaesoubi, Dumitru Chesov, Nelly Ciobanu, Alexandru Codreanu, Valeriu Crudu, Ted Cohen, Nicolas A Menzies
Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis. PLoS medicine 21 (5) (2024)
Lyndon P James, Fayette Klaassen, Sedona Sweeney, Jennifer Furin, Molly F Franke, Reza Yaesoubi, Dumitru Chesov, Nelly Ciobanu, Alexandru Codreanu, Valeriu Crudu, Ted Cohen, Nicolas A Menzies
Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis. PLoS medicine 21 (5) (2024)
Melike Hazal Can, Sedona Sweeney, Brian W Allwood, Susan E Dorman, Ted Cohen, Nicolas A Menzies
Implications of progressive lung damage and post-TB sequelae for the health benefits of prompt TB diagnosis in high HIV prevalence settings: a mathematical modeling analysis. medRxiv : the preprint server for health sciences (2024)
Lyndon P James, Fayette Klaassen, Sedona Sweeney, Jennifer Furin, Molly F Franke, Reza Yaesoubi, Dumitru Chesov, Nelly Ciobanu, Alexandru Codreanu, Valeriu Crudu, Ted Cohen, Nicolas A Menzies
Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis. PLoS medicine 21 (5) (2024)
Melike Hazal Can, Sedona Sweeney, Brian W Allwood, Susan E Dorman, Ted Cohen, Nicolas A Menzies
Implications of progressive lung damage and post-TB sequelae for the health benefits of prompt TB diagnosis in high HIV prevalence settings: a mathematical modeling analysis. medRxiv : the preprint server for health sciences (2024)
Anna Vassall, Sedona Sweeney, Edwine Barasa, Shankar Prinja, Marcus R Keogh-Brown, Henning Tarp Jensen, Richard Smith, Rob Baltussen, Rosalind M Eggo, Mark Jit
Integrating economic and health evidence to inform Covid-19 policy in low- and middle- income countries. Wellcome open research 5 (2022)
Sedona Sweeney, Catherine Berry, Emil Kazounis, Ilaria Motta, Anna Vassall, Matthew Dodd, Katherine Fielding, Bern-Thomas Nyang'wa
Cost-effectiveness of short, oral treatment regimens for rifampicin resistant tuberculosis. PLOS global public health 2 (12) (2022)
Sedona Sweeney, Anna Vassall, Lorna Guinness, Mariana Siapka, Natsayi Chimbindi, Don Mudzengi, Gabriela B Gomez
Examining Approaches to Estimate the Prevalence of Catastrophic Costs Due to Tuberculosis from Small-Scale Studies in South Africa. PharmacoEconomics 38 (6) (2021)
Sedona Sweeney, Theo Prudencio Juhani Capeding, Rosalind M M Eggo, Maryam Huda, Mark Jit, Don Mudzengi, Nichola R Naylor, Simon Procter, Matthew Quaife, Lela Serebryakova, Sergio Torres-Rueda, Veronica Vargas, null null, Anna Vassall
Exploring equity in health and poverty impacts of control measures for SARS-CoV-2 in six countries. BMJ global health 6 (5) (2021)
Carl A B Pearson, Fiammetta Maria Bozzani, Simon R Procter, Nicholas G Davies, Maryam Huda, Henning Tarp Jensen, Marcus Keogh-Brown, Muhammad Khalid, Sedona Sweeney, Sergio Torres-Rueda, null null, null null, Rosalind M M Eggo, Anna Vassall, Mark Jit
COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness. PLoS medicine 18 (10) (2021)
Sergio Torres-Rueda, Sedona Sweeney, Fiammetta Maria Bozzani, Nichola R Naylor, Tim Baker, Carl A B Pearson, Rosalind Eggo, Simon R Procter, Nicholas Davies, Matthew Quaife, Nichola Kitson, Marcus R Keogh-Brown, Henning Tarp Jensen, Nuru Saadi, Mishal Khan, Maryam Huda, Angela Kairu, Raza Zaidi, Edwine W Barasa, Mark Jit, Anna Vassall
Stark choices: exploring health sector costs of policy responses to COVID-19 in low-income and middle-income countries. BMJ global health 6 (12) (2021)
Sedona Sweeney, Gabriela Gomez, Nichola Kitson, Animesh Sinha, Natalia Yatskevich, Suzanne Staples, Ronelle Moodliar, Sharon Motlhako, Matshepo Maloma, Mohammed Rassool, Nosipho Ngubane, Ella Ndlovu, Bern-Thomas Nyang'wa
Cost-effectiveness of new MDR-TB regimens: study protocol for the TB-PRACTECAL economic evaluation substudy. BMJ open 10 (10) (2020)
Lucy Platt, Magdalena Harris, Sedona Sweeney
Commentary on Hancock et al. (2020): Low dead space syringes are just one component of an integrated package of care needed to tackle HCV and social exclusion among people who inject drugs. Addiction (Abingdon, England) 115 (4) (2020)
Anna Vassall, Sedona Sweeney, Edwine Barasa, Shankar Prinja, Marcus R Keogh-Brown, Henning Tarp Jensen, Richard Smith, Rob Baltussen, Rosalind M Eggo, Mark Jit
Integrating economic and health evidence to inform Covid-19 policy in low- and middle- income countries. Wellcome open research 5 (2020)
William Edward Rudgard, Carlton A Evans, Sedona Sweeney, Tom Wingfield, Knut Lönnroth, Draurio Barreira Cravo Neto, Delia Boccia
Comparison of two cash transfer strategies to prevent catastrophic costs for poor tuberculosis-affected households in low- and middle-income countries: An economic modelling study. PLoS medicine 14 (11) (2017)